Approval · Notice of Compliance 10157 · 2009
INFERGEN: Notice of Compliance 10157
Issued April 17, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10157
- Date
- April 17, 2009
- Company
- Three Rivers Pharmaceuticals LlcWarrendale, Pennsylvania, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFERGEN | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALFACON-1 0.03 MG per ML